CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
Cingulate Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$4.36+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $57.49M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.66 (+17.84%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $57.49M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.45
- Dividend yield
- –
- Free cash flow yield
- -36.42%
Fundamentals
- Net income
- -$28.80M
- EPS, diluted
- -$3.68
- Free cash flow
- -$20.94M
- Book value per share
- $1.78
- Diluted shares
- 13M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Operating income
-$24.92M
Net income
-$28.80M
EPS, diluted
-$3.68
Free cash flow
-$20.94M
Reported periodTrailing twelve months